Merit Medical Systems (NASDAQ:MMSI) Insider Brian Lloyd Sells 16,722 Shares of Stock

Key Points

  • Insider Brian Lloyd sold 16,722 Merit Medical shares at an average of $86.33, totaling about $1.44 million. The sale was made under a pre-arranged Rule 10b5-1 plan; Lloyd retained 60,132 shares.
  • Merit Medical beat quarterly estimates, reporting EPS of $1.12 versus $1.04 expected and revenue of $416.24 million versus $410.56 million. Revenue increased 8.4% year over year.
  • Analysts’ consensus rating is Moderate Buy, with an average price target of $105.91; eight analysts rate the stock Buy and five rate it Hold.

Merit Medical Systems, Inc. (NASDAQ:MMSI - Get Free Report) insider Brian Lloyd sold 16,722 shares of the business's stock in a transaction that occurred on Monday, November 16th. The shares were sold at an average price of $86.33, for a total transaction of $1,443,610.26. Following the transaction, the insider directly owned 60,132 shares in the company, valued at $5,191,195.56. The trade was a 21.76% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Merit Medical Systems Stock Down 2.2%

Merit Medical Systems stock opened at $84.49 on Wednesday. The firm has a market cap of $5.06 billion, a PE ratio of 31.76, a P/E/G ratio of 2.10 and a beta of 0.56. The company has a debt-to-equity ratio of 0.42, a quick ratio of 3.05 and a current ratio of 4.52. The firm's 50 day moving average price is $87.90 and its two-hundred day moving average price is $77.45. Merit Medical Systems, Inc. has a twelve month low of $59.74 and a twelve month high of $94.85.

Merit Medical Systems (NASDAQ:MMSI - Get Free Report) last issued its earnings results on Thursday, October 29th. The medical instruments supplier reported $1.12 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.04 by $0.08. The company had revenue of $416.24 million during the quarter, compared to analyst estimates of $410.56 million. Merit Medical Systems had a net margin of 9.94% and a return on equity of 14.12%. The company's revenue for the quarter was up 8.4% on a year-over-year basis. During the same quarter last year, the business posted $0.92 EPS. On average, research analysts predict that Merit Medical Systems, Inc. will post 3.86 EPS for the current fiscal year.

Wall Street Analyst Weigh In




MMSI has been the topic of a number of research reports. Weiss Ratings raised shares of Merit Medical Systems from a "hold (c)" rating to a "hold (c+)" rating in a research note on Monday, October 12th. Wells Fargo & Company lifted their price objective on Merit Medical Systems from $83.00 to $92.00 and gave the company an "equal weight" rating in a research report on Friday, October 30th. Zacks Research downgraded Merit Medical Systems from a "strong-buy" rating to a "hold" rating in a research note on Monday, October 19th. Freedom Capital began coverage on Merit Medical Systems in a research note on Tuesday, October 27th. They issued a "hold" rating on the stock. Finally, Barrington Research set a $114.00 target price on Merit Medical Systems in a research report on Friday, July 31st. Eight research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $105.91.

Check Out Our Latest Research Report on Merit Medical Systems

Hedge Funds Weigh In On Merit Medical Systems

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Kilter Group LLC bought a new stake in Merit Medical Systems in the second quarter worth approximately $25,000. Salomon & Ludwin LLC increased its stake in shares of Merit Medical Systems by 140.8% during the 3rd quarter. Salomon & Ludwin LLC now owns 537 shares of the medical instruments supplier's stock worth $46,000 after purchasing an additional 314 shares during the last quarter. IFP Advisors Inc increased its stake in shares of Merit Medical Systems by 88.6% during the 3rd quarter. IFP Advisors Inc now owns 694 shares of the medical instruments supplier's stock worth $60,000 after purchasing an additional 326 shares during the last quarter. Harbor Investment Advisory LLC bought a new position in shares of Merit Medical Systems during the 2nd quarter valued at $50,000. Finally, Pinnacle Wealth Planning Services Inc. raised its holdings in shares of Merit Medical Systems by 84.0% during the 3rd quarter. Pinnacle Wealth Planning Services Inc. now owns 784 shares of the medical instruments supplier's stock valued at $68,000 after purchasing an additional 358 shares in the last quarter. Institutional investors own 99.66% of the company's stock.

About Merit Medical Systems

(Get Free Report)

Merit Medical Systems develops, manufactures and markets medical devices used in diagnostic and interventional procedures. Its products support clinicians in areas including cardiology, radiology, oncology and endoscopy. The company's portfolio includes devices and accessories for vascular access, diagnostic and therapeutic procedures, drainage, biopsy and embolization. Merit serves hospitals, clinics and other healthcare providers through direct sales and distribution channels. Founded in 1987 and headquartered in South Jordan, Utah, Merit Medical serves customers in the United States and internationally.

See Also

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at Merit Medical Systems?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Merit Medical Systems and related companies.
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles